Multimodal pore formation in calcium phosphate cements.

Calcium phosphate cements (CPCs) are widely used in bone regeneration due to their biocompatibility. However, their slow degradation rate limits new bone formation. Current approaches involve incorporating biodegradable polymers like PLGA to enhance CPC degradation. PLGA degrades over weeks, which delays pore formation and tissue ingrowth. Prior research has shown that PLGA can accelerate CPC degradation through acidic by-products. Yet, this delay hinders early bone regeneration. That uncertainty drove the need for a method to initiate pore formation sooner. No prior work had resolved how to trigger early macroporosity without relying on PLGA alone. This gap motivated the investigation of additional porogens to complement PLGA in CPC composites.

The aim of this study was to accelerate early pore formation in calcium phosphate cements (CPCs) without relying solely on PLGA degradation. Researchers sought to introduce a water-soluble porogen to initiate macroporosity at an earlier stage. The specific problem addressed is the delay in new bone formation caused by the slow degradation of PLGA. The motivation stems from the need to improve tissue ingrowth and replacement of CPCs in the early post-implantation period. The study focused on combining sucrose with CPC and CPC/PLGA composites to evaluate early pore formation. The goal was to determine if sucrose could complement PLGA in promoting multimodal porosity. The researchers aimed to assess both early and late-stage porosity formation. This approach could potentially improve the clinical performance of CPCs in bone regeneration.

The study used calcium phosphate cements (CPCs) as the base material for all experiments. Researchers prepared CPC samples with and without poly(dl-lactic-co-glycolic acid) (PLGA). Sucrose was added at 10 or 20 weight percentages to create porogen-containing composites. The samples were analyzed for mass loss during in vitro degradation over a period of weeks. Macroporosity was assessed using imaging and porosity analysis techniques. The degradation behavior of CPC, PLGA, and sucrose was tracked separately and in combination. The study compared the effects of sucrose alone versus sucrose in combination with PLGA. Researchers monitored how each component contributed to pore formation at different time points. The results were evaluated to determine the effectiveness of multimodal porosity formation.

The results showed that sucrose incorporation increased mass loss within the first week of in vitro degradation. Groups containing sucrose exhibited greater early mass loss compared to control groups without porogens. After the first week, mass loss continued due to the degradation of PLGA and CPC. Macroporosity analysis confirmed that early pore formation was driven by sucrose dissolution. Later pore formation was attributed to PLGA and CPC degradation. The combination of sucrose and PLGA led to a more complex pore structure over time. The study found that sucrose accelerated early-stage porosity formation. The findings suggest that multimodal porosity formation can enhance tissue ingrowth and CPC replacement.

The authors concluded that combining sucrose and PLGA porogens in CPC is a promising strategy for promoting early bone tissue ingrowth. The study demonstrated that sucrose can initiate macroporosity formation at an earlier stage than PLGA alone. The combination of both porogens led to a more gradual and multimodal degradation process. This approach may improve the clinical performance of CPCs in bone regeneration. The results suggest that early pore formation can enhance tissue integration and replacement of CPCs. The study did not propose that sucrose alone is sufficient for long-term degradation. The findings support the use of multimodal porosity formation to optimize CPC performance. The authors did not claim that this method is essential for all CPC applications.